© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Fortrea Holdings Inc. (FTRE) stock declined over -0.21%, trading at $14.58 on NASDAQ, down from the previous close of $14.61. The stock opened at $14.58, fluctuating between $14.33 and $14.78 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 12, 2026 | 14.89 | 14.97 | 14.16 | 14.61 | 1.34M |
| May 11, 2026 | 15.43 | 15.46 | 14.84 | 14.99 | 1.2M |
| May 08, 2026 | 15.59 | 15.61 | 14.71 | 15.43 | 1.39M |
| May 07, 2026 | 15.64 | 16.20 | 15.27 | 15.57 | 1.63M |
| May 06, 2026 | 14.85 | 15.80 | 14.53 | 15.64 | 2.87M |
| May 05, 2026 | 13.97 | 15.61 | 13.96 | 14.53 | 4.23M |
| May 04, 2026 | 12.19 | 12.32 | 11.73 | 12.25 | 2.16M |
| Apr 30, 2026 | 10.53 | 11.60 | 10.50 | 11.50 | 2.33M |
| Apr 29, 2026 | 10.70 | 11.12 | 10.43 | 10.56 | 2.96M |
| Apr 28, 2026 | 10.61 | 10.89 | 10.48 | 10.76 | 1.47M |
| Apr 27, 2026 | 9.72 | 10.65 | 9.64 | 10.60 | 1.77M |
| Apr 23, 2026 | 10.27 | 10.38 | 9.20 | 9.63 | 1.68M |
| Apr 22, 2026 | 10.53 | 10.73 | 10.17 | 10.50 | 900.25K |
| Apr 21, 2026 | 10.44 | 10.99 | 10.22 | 10.32 | 1.08M |
| Apr 20, 2026 | 10.20 | 10.52 | 10.18 | 10.44 | 590.15K |
| Apr 17, 2026 | 10.40 | 10.54 | 10.14 | 10.38 | 750.06K |
| Apr 16, 2026 | 10.03 | 10.59 | 9.97 | 10.09 | 1.52M |
| Apr 14, 2026 | 9.47 | 9.71 | 9.46 | 9.59 | 600.26K |
| Apr 13, 2026 | 9.07 | 9.56 | 8.94 | 9.38 | 676.9K |
| Apr 10, 2026 | 9.38 | 9.51 | 8.94 | 9.18 | 583.9K |
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
| Employees | 15000 |
| Beta | 1.78 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | 0.097% |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |